Form 4: Perrigo Executive Reports Stock Unit Vesting

Matthew John Winterman of Perrigo Company plc reports the vesting of 70,688 Restricted Stock Units, converting them into ordinary shares.

Summary

• Matthew John Winterman, EVP of Supply, Operations, and Strategy at Perrigo Company plc, reported a transaction on July 8, 2026.
• This transaction involved the vesting of 70,688 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• Following the vesting, these RSUs converted into 70,688 ordinary shares, which are beneficially owned directly by Mr. Winterman.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine executive stock unit vesting and does not indicate new financial performance or strategic shifts.

Positives

• Vesting of stock units indicates potential long-term incentive alignment for executive leadership.
• The executive directly holds the resulting ordinary shares, suggesting continued commitment to the company.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executive stock transactions, providing transparency into insider holdings and compensation structures within the pharmaceutical and consumer healthcare sectors.

Stakeholder Impact

• Shareholders: Increased transparency into executive holdings and compensation structure.

Key Dates

Keywords

Form 4, SEC Filing, Perrigo Company plc, PRGO, Stock Options, Restricted Stock Units, Executive Compensation, Insider Trading, Beneficial Ownership